# Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia

> **NCT00081887** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia
- Leukemia

## Interventions

- **DRUG:** Clofarabine

## Key facts

- **NCT ID:** NCT00081887
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** 2007-05
- **Final completion:** 2007-06
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2012-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081887, "Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00081887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*